Askgene Limited Announces Completion Of Usd 20 Million Series A Financing Led By Qiming Venture Partners And Tf Capital
May 09, 2022•about 3 years ago
Amount Raised
$20 Million
Round Type
series a
Description
AskGene Limited ("AskGene"), a clinical-stage biopharmaceutical company focusing on discovery and development of innovative biological drugs, today announced the completion of USD 20 million in Series A financing. The financing was led by Qiming Venture Partners and TF Capital. Proceeds from the financing will be used to advance clinical development of AskGene's robust pipeline of innovative therapeutic candidates and development of SmartKine® cytokine prodrug platform.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech